These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 30334971)

  • 61. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma.
    Mascarenhas RC; Sanghvi AN; Friedlander L; Geyer SJ; Beasley HS; Van Thiel DH
    Oncology; 2004; 67(5-6):471-5. PubMed ID: 15714004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 64.
    Xiao L; Zhang W; Li L
    Hell J Nucl Med; 2022; 25(1):106-107. PubMed ID: 35388808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
    Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pseudomyogenic Hemangioendothelioma Mimicking Multiple Myeloma on 18F-FDG PET/CT, Followed by Spontaneous Regression.
    Bryanton M; Makis W
    Clin Nucl Med; 2015 Jul; 40(7):579-81. PubMed ID: 26018681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discordant results in
    Parisse-Di Martino S; Faure C; Mognetti T
    Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    Petrović J; Beatović S; Šobić-Šaranović D; Odalović S; Stojiljković M; Grozdic-Milojevic I; Veljkovic M; Jovanovic D; Artiko V
    Hell J Nucl Med; 2022; 25(1):19-25. PubMed ID: 35388800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
    Goshen E; Davidson T; Zwas ST; Aderka D
    Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pulmonary epithelioid hemangioendothelioma: Nuclear medicine and 18F-FDG PET/CT findings.
    Yang M; Nguyen BD; Roarke MC
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):393-5. PubMed ID: 25805048
    [No Abstract]   [Full Text] [Related]  

  • 72. Multiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.
    Sun L; Wan Y; Lin Q; Sun YH; Zhao L; Luo ZM; Wu H
    World J Gastroenterol; 2010 Aug; 16(31):3964-9. PubMed ID: 20712059
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
    Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Subtype-Guided
    Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
    Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of
    Delgado Bolton RC; Calapaquí-Terán AK; Giammarile F; Rubello D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):229-233. PubMed ID: 31202725
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
    Bao C; Wei J; Zhao X; Lin L; Chen D; Liu K; Qian W; Anas JM; Zhao K
    Medicine (Baltimore); 2018 Mar; 97(10):e9877. PubMed ID: 29517697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 3'-Deoxy-3'-
    Kim JE; Chae SY; Kim JH; Kim HJ; Kim TW; Kim KP; Kim SY; Lee JL; Oh SJ; Kim JS; Ryu JS; Moon DH; Hong YS
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1713-1722. PubMed ID: 31041456
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
    Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
    Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.